Citation 148978

FUKAI,T: SAKAGAMI,H: TOGUCHI,M: TAKAYAMA,F: IWAKURA,I: ATSUMI,T: UEHA,T: NAKASHIMA,H: NOMURA,T:. (2000). CYTOTOXIC ACTIVITY OF LOW MOLECULAR WEIGHT POLYPHENOLS AGAINST HUMAN ORAL TUMOR CELL LINES.. 20(4)

Citation Details

Title	CYTOTOXIC ACTIVITY OF LOW MOLECULAR WEIGHT POLYPHENOLS AGAINST HUMAN ORAL TUMOR CELL LINES.
Authors	FUKAI,T: SAKAGAMI,H: TOGUCHI,M: TAKAYAMA,F: IWAKURA,I: ATSUMI,T: UEHA,T: NAKASHIMA,H: NOMURA,T:
Year	2000
Volume	20
Issue	4

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN	INACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN	INACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN	INACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN,6-PRENYL:	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PINOCEMBRIN,6-PRENYL:	INACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRANIN	WEAK ACTIVITY
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRANIN	INACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	EQUIVOCAL
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,6-PRENYL:	EQUIVOCAL
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,8-PRENYL:	EQUIVOCAL
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,8-PRENYL:	INACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL,8-PRENYL:	EQUIVOCAL
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ERIODICTYOL,8-PRENYL:	INACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SIGMOIDIN B	EQUIVOCAL
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SIGMOIDIN B	EQUIVOCAL
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE F	EQUIVOCAL
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE F	INACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABROL	WEAK ACTIVITY
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABROL	INACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABROL	WEAK ACTIVITY
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABROL	WEAK ACTIVITY
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,3'-6-DIPRENYL:	WEAK ACTIVITY
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN,3'-6-DIPRENYL:	WEAK ACTIVITY
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN E	WEAK ACTIVITY
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN E	INACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN E	WEAK ACTIVITY
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN E	EQUIVOCAL
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SIGMOIDIN A	WEAK ACTIVITY
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SIGMOIDIN A	INACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE I	WEAK ACTIVITY
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE I	WEAK ACTIVITY
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE I	WEAK ACTIVITY
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE I	WEAK ACTIVITY
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE G	WEAK ACTIVITY
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE G	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE H	WEAK ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIARONE H	INACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABROL,3-HYDROXY:	EQUIVOCAL
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABROL,3-HYDROXY:	WEAK ACTIVITY
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGGENOL C	WEAK ACTIVITY
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SANGGENOL C	INACTIVE
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN	WEAK ACTIVITY
44	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN	ACTIVE
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN	WEAK ACTIVITY
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRIDIN	WEAK ACTIVITY
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN C	EQUIVOCAL
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN C	EQUIVOCAL
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN C	WEAK ACTIVITY
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN C	EQUIVOCAL
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPIRIN D	EQUIVOCAL
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPIRIN D	INACTIVE
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPAGLABRIDIN A	WEAK ACTIVITY
54	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	HISPAGLABRIDIN A	INACTIVE
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KANZONOL H	EQUIVOCAL
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KANZONOL H	INACTIVE
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCORICIDIN	WEAK ACTIVITY
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCORICIDIN	WEAK ACTIVITY
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICORISOFLAVAN A	WEAK ACTIVITY
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRENE	WEAK ACTIVITY
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRENE	WEAK ACTIVITY
62	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN C,DEHYDRO:	WEAK ACTIVITY
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN C,DEHYDRO:	WEAK ACTIVITY
64	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN C,DEHYDRO:	WEAK ACTIVITY
65	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN C,DEHYDRO:	INACTIVE
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAZINOL B	WEAK ACTIVITY
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAZINOL B	WEAK ACTIVITY
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAZINOL E	WEAK ACTIVITY
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAZINOL E	WEAK ACTIVITY
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M	INACTIVE
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN M	INACTIVE
72	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN C	WEAK ACTIVITY
73	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN C	WEAK ACTIVITY
74	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN P	EQUIVOCAL
75	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORACIN P	WEAK ACTIVITY
76	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN I	EQUIVOCAL
77	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN I	INACTIVE
78	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANOL A	WEAK ACTIVITY
79	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANOL A	ACTIVE
80	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANOL B	ACTIVE
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANOL B	WEAK ACTIVITY
82	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANOL B	ACTIVE
83	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALBANOL B	WEAK ACTIVITY
84	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	WEAK ACTIVITY
85	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
86	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	INACTIVE
87	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	WEAK ACTIVITY
88	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	INACTIVE
89	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	INACTIVE
90	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AFROMOSIN	INACTIVE
91	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AFROMOSIN	INACTIVE
92	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRONE	EQUIVOCAL
93	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLABRONE	EQUIVOCAL
94	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICORICONE	EQUIVOCAL
95	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICORICONE	INACTIVE
96	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SEMILICOISOFLAVONE B	INACTIVE
97	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SEMILICOISOFLAVONE B	WEAK ACTIVITY
98	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOISOFLAVONE B	EQUIVOCAL
99	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOISOFLAVONE B	WEAK ACTIVITY
100	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOISOFLAVONE A	INACTIVE
101	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOISOFLAVONE A	WEAK ACTIVITY
102	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	WIGHTEONE	WEAK ACTIVITY
103	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	WIGHTEONE	WEAK ACTIVITY
104	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	WIGHTEONE	WEAK ACTIVITY
105	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	WIGHTEONE	EQUIVOCAL
106	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN G	WEAK ACTIVITY
107	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN G	EQUIVOCAL
108	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN C	INACTIVE
109	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN C	WEAK ACTIVITY
110	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN B	EQUIVOCAL
111	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN B	INACTIVE
112	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AUGUSTONE B	WEAK ACTIVITY
113	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AUGUSTONE B	WEAK ACTIVITY
114	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN H	INACTIVE
115	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN H	WEAK ACTIVITY
116	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	WIGHTEONE,8-PRENYL:	WEAK ACTIVITY
117	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	WIGHTEONE,8-PRENYL:	WEAK ACTIVITY
118	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOISOFLAVANONE	INACTIVE
119	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOISOFLAVANONE	EQUIVOCAL
120	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN B	EQUIVOCAL
121	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYASPERIN B	WEAK ACTIVITY
122	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KIEVITONE,3'-PRENYL:	WEAK ACTIVITY
123	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KIEVITONE,3'-PRENYL:	WEAK ACTIVITY
124	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DALBERGIOIDIN,3'-6-DIPRENYL:	WEAK ACTIVITY
125	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DALBERGIOIDIN,3'-6-DIPRENYL:	EQUIVOCAL
126	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYCOUMARIN	EQUIVOCAL
127	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYCOUMARIN	WEAK ACTIVITY
128	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRIN	WEAK ACTIVITY
129	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRIN	WEAK ACTIVITY
130	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYROL	ACTIVE
131	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYROL	WEAK ACTIVITY
132	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYROL,ISO:	WEAK ACTIVITY
133	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYROL,ISO:	INACTIVE
134	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYROL,ISO:	WEAK ACTIVITY
135	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYROL,ISO:	INACTIVE
136	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN	EQUIVOCAL
137	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN	INACTIVE
138	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHASEOLLIDIN,1-METHOXY:	EQUIVOCAL
139	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHASEOLLIDIN,1-METHOXY:	WEAK ACTIVITY
140	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FICIFOLINOL,1-METHOXY:	ACTIVE
141	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FICIFOLINOL,1-METHOXY:	WEAK ACTIVITY
142	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FICIFOLINOL,1-METHOXY:	ACTIVE
143	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FICIFOLINOL,1-METHOXY:	WEAK ACTIVITY
144	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY:	ACTIVE
145	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY:	ACTIVE
146	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY:	WEAK ACTIVITY
147	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHALCONE,2'-HYDROXY:	WEAK ACTIVITY
148	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO:	WEAK ACTIVITY
149	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO:	WEAK ACTIVITY
150	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ECHINATIN	EQUIVOCAL
151	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ECHINATIN	WEAK ACTIVITY
152	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOCHALCONE B	ACTIVE
153	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOCHALCONE B	WEAK ACTIVITY
154	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOCHALCONE B	WEAK ACTIVITY
155	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOCHALCONE B	INACTIVE
156	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOCHALCONE B	WEAK ACTIVITY
157	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICOCHALCONE B	WEAK ACTIVITY
158	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CORDOIN,ISO: 4-HYDROXY:	EQUIVOCAL
159	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CORDOIN,ISO: 4-HYDROXY:	WEAK ACTIVITY
160	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BAVACHLCONE	WEAK ACTIVITY
161	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BAVACHLCONE	ACTIVE
162	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICURASIDE	INACTIVE
163	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICURASIDE	INACTIVE
164	BACTERIAL STIMULANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICODIONE,2'-O-METHYL:	INACTIVE
165	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LICODIONE,2'-O-METHYL:	WEAK ACTIVITY
166	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYINFLANIN B	EQUIVOCAL
167	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYINFLANIN B	EQUIVOCAL
168	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYINFLANIN C	WEAK ACTIVITY
169	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYINFLANIN C	WEAK ACTIVITY
170	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN R	WEAK ACTIVITY
171	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN R	WEAK ACTIVITY
172	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN R	WEAK ACTIVITY
173	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN R	WEAK ACTIVITY
174	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN S	WEAK ACTIVITY
175	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN S	ACTIVE
176	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN S	WEAK ACTIVITY
177	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN S	WEAK ACTIVITY
178	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN V	EQUIVOCAL
179	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN V	WEAK ACTIVITY
180	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN U	WEAK ACTIVITY
181	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN U	ACTIVE
182	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN U	WEAK ACTIVITY
183	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN U	WEAK ACTIVITY
184	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAZINOL N	WEAK ACTIVITY
185	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAZINOL N	WEAK ACTIVITY
186	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAZINOL F	WEAK ACTIVITY
187	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAZINOL F	WEAK ACTIVITY
188	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN Q	WEAK ACTIVITY
189	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GANCAONIN Q	WEAK ACTIVITY
190	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	WEAK ACTIVITY
191	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	INACTIVE
192	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
193	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
194	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	WEAK ACTIVITY
195	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	INACTIVE
196	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	INACTIVE

Citation 148978

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1